Validation and adjustment of modified Erasmus GBS outcome score in Bangladesh.

ABSTRACT:

Objective

We have assessed and improved the performance of the modified Erasmus GBS Outcome Score (mEGOS) among patients with Guillain-Barré syndrome (GBS) from Bangladesh.

Methods

Validation cohort consisted of patients with GBS from two prospective cohort studies in Bangladesh. Poor outcome was defined as being unable to walk independently at week 4 and week 26. We excluded patients able to walk independently, patients who died within the first week, or with missing GBS disability scores. Performance of mEGOS at entry and week 1 was determined based on the discriminative ability (ability to differentiate between patients able and unable to walk independently; measured using the area under the receiver operating characteristic curves [AUC]) and calibration (observed probabi

SUBMITTER: Papri N 

PROVIDER: S-EPMC9380155 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature